Interventional Radiology Research Lab

The Interventional Radiology Research Lab (IRRL) is a multi-disciplinary research group whose studies focus on basic, translational and clinical aspects of image-guided therapy. In collaboration with a large number of internal and external academic partners and external industry partners, the IR Lab’s accomplishments included novel endovascular devices, imaging techniques, in vitro and animal models of disease, and industry standard support of multi-center, international clinical device trials. The IR Lab has grown rapidly since its inception; over 100 papers have been published and $4.5 million have been awarded in grant funding from various government and industry sponsors.

Research

ChemoFilter

Developing a family of novel ChemoFilter devices to remove drugs from the blood; this work has also led to additional sponsored funding as well as formation of a startup company.

Interventional MRI

Developing tools to perform endovascular stroke treatment under 3T MRI guidance so stroke patients can be treated in any 3T MRI scanner or in a combined X-ray/MRI (XMR) suite

Grants

NIH R01: Endovascular Chemofiltration: Optimizing remov of chemotherapeutics and nanoparticles from the blood to reduce toxicity (current)
NIH R01: MARC – Magnetic Assisted Remote Control Catheter (in renewal)
NIH R21: Improved sensitivity and safety for endovascular MR imaging at 3T (current)
UCSF Radiology Seed Grant: PET/MR Quantification of Multifunctional Magnetic Nanoparticles for Targeted Chemotherapy (current)